Perspective Therapeutics Files 2024 Annual Report Amendment

Ticker: CATX · Form: 10-K/A · Filed: Mar 28, 2025 · CIK: 728387

Sentiment: neutral

Topics: amendment, annual-report, company-name-change

TL;DR

Perspective Therapeutics (formerly Isoray) filed its 2024 10-K amendment on March 28, 2025.

AI Summary

Perspective Therapeutics, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ending December 31, 2024. The filing, submitted on March 28, 2025, includes information related to its business operations, financial condition, and previous filings. Notably, the company was formerly known as Isoray, Inc. and has undergone name changes dating back to 1992.

Why It Matters

This amendment provides updated and potentially corrected information for the fiscal year 2024, which is crucial for investors and stakeholders to assess the company's performance and financial health.

Risk Assessment

Risk Level: low — This filing is an amendment to a previous annual report and does not appear to introduce new material risks or significant financial changes.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this 10-K/A filing?

This 10-K/A filing is an amendment to the annual report for the fiscal year ended December 31, 2024, filed by Perspective Therapeutics, Inc.

When was this amendment filed with the SEC?

The amendment was filed on March 28, 2025.

What was Perspective Therapeutics, Inc. formerly known as?

Perspective Therapeutics, Inc. was formerly known as Isoray, Inc., and prior to that, CENTURY PARK PICTURES CORP.

What is the SIC code for Perspective Therapeutics, Inc.?

The Standard Industrial Classification (SIC) code for Perspective Therapeutics, Inc. is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

What is the business address of Perspective Therapeutics, Inc.?

The business address is 2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA 98121.

Filing Details

This Form 10-K/A (Form 10-K/A) was filed with the SEC on March 28, 2025 regarding Perspective Therapeutics, Inc. (CATX).

View full filing on EDGAR

View Full Filing

View this 10-K/A filing on SEC EDGAR

View on Read The Filing